Kate Sears retweeted
Team India 🇮🇳 🇮🇳 🇮🇳 #UromigosLive show the size of the opportunities in this rapidly growing country. @shilpaonc & @adidhanawat
The @Uromigos meeting starts a week today ,
Bladder cancer livestream 2pm EST .
@OncoAlert
The @Uromigos meeting starts a week today ,
Bladder cancer livestream 2pm EST .
@OncoAlert
🇮🇳 Team India is brewing up some competition at the Uromigos World Cup! ☕⚽🏆
It's Chai Pe Charcha time! From Mumbai to Cleveland, Team India is exploring whether low-dose immunotherapy could make cancer treatment more affordable and what it might mean for bladder cancer.
ion! ☕
🎥 : @shilpaonc & @adidhanawat | #UromigosLive
2
12
26
1,415
Kate Sears retweeted
Dr. Rebecca Snyder on developments in pancreas surg: less about changing what happens in the OR, more about everything around it - integrating targeted tx & better biomarkers for pt selection.
💯 agree these innovations = key to improving outcomes across local tx, including RT.
💯 agree these innovations = key to improving outcomes across local tx, including RT.
0
3
10
728
Kate Sears retweeted
🇮🇳 Team India is brewing up some competition at the Uromigos World Cup! ☕⚽🏆
It's Chai Pe Charcha time! From Mumbai to Cleveland, Team India is exploring whether low-dose immunotherapy could make cancer treatment more affordable and what it might mean for bladder cancer.
ion! ☕
🎥 : @shilpaonc & @adidhanawat | #UromigosLive
It's Chai Pe Charcha time! From Mumbai to Cleveland, Team India is exploring whether low-dose immunotherapy could make cancer treatment more affordable and what it might mean for bladder cancer.
ion! ☕
🎥 : @shilpaonc & @adidhanawat | #UromigosLive
9
31
92
8,686
Kate Sears retweeted
@OncBrothers @montypal @BijoyTelivala @RenoHemonc @DrYukselUrun @nataliagandur @AmandaNizamMD @SuyogCancer @MikeSerzanMD @bergsa83 @OncUpdates @drenriquegrande And we have a wonderful Livimg Algorithm from Monty to guide us, like having him next to us in clinic.
@OpenMedKate @OpenMedicineHQ @DrChoueiri @wandering_gu
myopenmedicine.com/algorithms/loc…
@OpenMedKate @OpenMedicineHQ @DrChoueiri @wandering_gu
myopenmedicine.com/algorithms/loc…
0
6
10
313
Kate Sears retweeted
For the latest episode of the @TheGutOncLab we had none other than the president of @NANETS1 Simron Singh to discuss (surprise) NETs and Radioligands.
We (mostly @UGrewalMD and Simron) had a great discussion about what is here now for NET patients, like NETTER-2, how to manage asing armamentarium of therapeutics, and what is coming in the future.
Available on Apple, Spotify and Onconexus.
@Onco_Nexus
open.spotify.com/episode/2OYpox…
oncologynexus.com/podcast/gut-on…
We (mostly @UGrewalMD and Simron) had a great discussion about what is here now for NET patients, like NETTER-2, how to manage asing armamentarium of therapeutics, and what is coming in the future.
Available on Apple, Spotify and Onconexus.
@Onco_Nexus
open.spotify.com/episode/2OYpox…
oncologynexus.com/podcast/gut-on…
0
6
16
962
Kate Sears retweeted
When should I order the serum
free light-chain assay, and how
should I interpret mild kappa
or lambda elevations
ccjm.org/content/93/8/4…
free light-chain assay, and how
should I interpret mild kappa
or lambda elevations
ccjm.org/content/93/8/4…
0
11
57
3,170
Kate Sears retweeted
Infection PPx with bispecific antibodies in myeloma: is IVIG the answer?
…. Yes, but not so simple.
Come join @JoshuaRichterMD and me next Thursday (Nov 12th, 6pm ET = 3pm PT) as we share what we know and what we’ve seen!
Bactrim, vaccines, SCIG, and more. See you then!
…. Yes, but not so simple.
Come join @JoshuaRichterMD and me next Thursday (Nov 12th, 6pm ET = 3pm PT) as we share what we know and what we’ve seen!
Bactrim, vaccines, SCIG, and more. See you then!
3
8
22
1,812
Kate Sears retweeted
Everything you need to know on the perioperative management of carcinoid crisis.
And you are hearing this from the medical oncologist with 10 thumbs who has not been in the OR since med school (with the exception of bone marrow harvesting for transplant as a fellow)...
Fantastic job, @HalletJulie @spartelli @FlavioRochaMD @JaydiDelRivero and others!
academic.oup.com/bjsopen/articl…?
And you are hearing this from the medical oncologist with 10 thumbs who has not been in the OR since med school (with the exception of bone marrow harvesting for transplant as a fellow)...
Fantastic job, @HalletJulie @spartelli @FlavioRochaMD @JaydiDelRivero and others!
academic.oup.com/bjsopen/articl…?
1
10
32
2,557
Kate Sears retweeted
Looking fwd to joining @benlevylungdoc & #TiffanyTrainaMD at the 44th Annual Chemotherapy Foundation Symposium next week in #NYC#NYCe meeting is so much more than the name implies - we will tackle the latest developments in the field across a spectrum of malignancies. Do join us! @OncoAlert
📢 Join us at the 44th Annual Chemotherapy Foundation Symposium (CFS®): Innovative Cancer Therapy for Tomorrow** NEXT WEEK!!! In Person + Online
🎟️ FREE REGISTRATION with code: ONCOALERT
👉 buff.ly/b5A7hsf
📅 November 11–13, 2026
📍 New York, NY 🇺🇸
💻 Hybrid Meeting — more than four decades, CFS® has brought together oncology professionals from around the world to explore the latest advances in cancer care.
This 3-day meeting will feature internationally renowned experts discussing practice-changing developments across **solid tumors and hematologic malignancies**, including:
🔹 Targeted therapies & immunotherapies\
🔹 Novel biomarkers and biomarker-driven treatment approaches\
🔹 Results from pivotal clinical trials\
🔹 Personalized treatment strategies based on evolving evidence\
🔹 Management of adverse events associated with novel therapies\
🔹 Emerging combination treatment strategies
🎓 Program Co-Chairs:
• Benjamin Levy, MD\
• John Mascarenhas, MD\
• Tiffany Traina, MD, FASCO
Don't miss this opportunity to connect with leaders in oncology, stay up to date on the latest evidence, and explore what’s next in cancer care.
@KCArbourMD @mishabeltran @KellyLBolton @HosseinBorghaei @AjaiChari @End\_myeloma @DrPinkalDesai @FordePatrick @MattGalsky @YJanjigianMD @DrHKantarjian @montypal @szusmani @HelenaYu923 @gotoPER
0
14
17
930
Kate Sears retweeted
Video-demo: LIVING @OpenMedicineHQ Algorithm.
#myeloma
#OpenMedicine
#mmsm
@ManniMD1
Link: myopenmedicine.com/algorithms/mul…
#myeloma
#OpenMedicine
#mmsm
@ManniMD1
Link: myopenmedicine.com/algorithms/mul…
· Open Medicine Algorithm Spotlight ·
Sharing a practical LIVING @OpenMedicineHQ algorithm Multiple Myeloma at First Relapse: Treatment by Drug Sensitivity and Clinical Context (Last updated TODAY, November 6, 2026) by @ManniMD1
💭Key point: Finite-duration bispecific therapy, including approximately 6–12 months in selected contexts, is an individualized expert-practice or investigational stopping strategy—not a universal standard.
👉🏻LIVING ASCO GUIDELINE: ascopubs.org/doi/10.1200/JC…
👉🏻LIVING algorithm link: myopenmedicine.com/algorithms/mul…
#OpendMedicine
#Myeloma
#mmsm
@OpenMedKate
@scserendipity1
0
4
7
336
Kate Sears retweeted
#ASH26 #AML #leusm Real-world outcomes HMA, venetoclax, and gilteritinib versus HMA and venetoclax alone in patients with newly diagnosed and R/R acute myeloid leukemia harboring a FLT3 mutation: An analysis from the MARROW consortium onlineprogram.hematology.org/paper-details.…
0
6
18
1,349
Kate Sears retweeted
· Open Medicine Algorithm Spotlight ·
Sharing a practical LIVING @OpenMedicineHQ algorithm Multiple Myeloma at First Relapse: Treatment by Drug Sensitivity and Clinical Context (Last updated TODAY, November 6, 2026) by @ManniMD1
💭Key point: Finite-duration bispecific therapy, including approximately 6–12 months in selected contexts, is an individualized expert-practice or investigational stopping strategy—not a universal standard.
👉🏻LIVING ASCO GUIDELINE: ascopubs.org/doi/10.1200/JC…
👉🏻LIVING algorithm link: myopenmedicine.com/algorithms/mul…
#OpendMedicine
#Myeloma
#mmsm
@OpenMedKate
@scserendipity1
Sharing a practical LIVING @OpenMedicineHQ algorithm Multiple Myeloma at First Relapse: Treatment by Drug Sensitivity and Clinical Context (Last updated TODAY, November 6, 2026) by @ManniMD1
💭Key point: Finite-duration bispecific therapy, including approximately 6–12 months in selected contexts, is an individualized expert-practice or investigational stopping strategy—not a universal standard.
👉🏻LIVING ASCO GUIDELINE: ascopubs.org/doi/10.1200/JC…
👉🏻LIVING algorithm link: myopenmedicine.com/algorithms/mul…
#OpendMedicine
#Myeloma
#mmsm
@OpenMedKate
@scserendipity1
0
6
9
590
Kate Sears retweeted
Metastatic Non-Small Cell Lung Cancer (NSCLC) Biomarker-Guided Treatment from @GlopesMd @Jani_Chinmay: myopenmedicine.com/algorithms/met…
1
5
5
298
Hi friends, it's #ProstateCancer Friday! Here are Top Posts of the Week 🧵
1/ @scocmem on talazoparib + enza vs placebo + enza in mCRPC (TALAPRO-2):
x.com/scocmem/status…
1/ @scocmem on talazoparib + enza vs placebo + enza in mCRPC (TALAPRO-2):
x.com/scocmem/status…
New biomarker analysis from TALAPRO-2 @TheLancetOncol
Baseline ctDNA and early dynamics correlated with rPFS, adding prognostic value beyond PSA in some patients
Integrating ctDNA, circulating tumour cells and PSA warrants further exploration @OncoAlert
sciencedirect.com/science/articl…
2
7
10
602
🚀 Is GU oncology becoming one of the most exciting fields for molecular imaging & theranostics?
PSMA in prostate cancer, CAIX in clear-cell RCC, and emerging NECTIN4-targeted approaches in urothelial cancer!
Fantastic to see CAIX imaging on the cover of The Lancet Medical ImagIX is a particularly elegant target: VHL loss → HIF stabilization → CAIX upregulation in ccRCC.
Using tumor biology wisely! 🧬
The opportunity goes beyond detecting disease: molecular imaging could enable patient selection, visualize target heterogeneity and potentially guide radioligand therapy.
Of course, CAIX-directed theranostics still require prospective validation, particularly of therapeutic efficacy and safety.
Exciting times for precision GU oncology! 👏
Read here: sciencedirect.com/science/articl…
@ProfKHerrmann
#KidneyCancer #Theranostics #GUOncology
@weoncologists @urotoday @Uromigos
@OncoAlert and Faculty: @DrChoueiri @tompowles1 @apolo_andrea @neerajaiims @montypal @Silke_Gillessen @AOmlin @brian_rini @PGrivasMDPhD @TiansterZhang @amerseburger @DrDanielHeng @HHammersMD @scocmem @AndreaNecchi @AmandaNizamMD @drenriquegrande @nataliagandur @AlbigesL @cdanicas @declangmurphy @seanmmcbride @shilpaonc @DrRanaMcKay @scserendipity1 @DrYukselUrun @ravikanesvaran @BraunMDPhD @EfstathiouEleni @mzugman @crisbergerot @Markuseckstein3
1
1
4
93
Love #MedTwitter but not the noise? Get practice changing updates from social media.
Subscribe to our weekly newsletter and join your colleagues. Sign up free!
my.medical.watch
Subscribe to our weekly newsletter and join your colleagues. Sign up free!
my.medical.watch
0
0
3
29
Kate Sears retweeted
Follicular lymphoma 2027 • ANNUAL CLINICAL UPDATES IN HEMATOLOGICAL MALIGNANCIES
onlinelibrary.wiley.com/doi/10.1002/aj…
@AjHematology
onlinelibrary.wiley.com/doi/10.1002/aj…
@AjHematology
4
27
80
5,460